6-amino-3,4-dihydroquinolin-2(1H)-one → HCID 44467318, compound

HRID 2381773Notes

Reaction equation

HRID 2381773 reaction equation
Cl[C:2]1[N:7]=[C:6]([N:8]2[CH2:13][CH2:12][CH:11]([CH2:14][NH:15]C(=O)OC(C)(C)C)[CH2:10][CH2:9]2)[C:5]([CH:23]2[CH2:25][CH2:24]2)=[CH:4][N:3]=1.[NH2:26][C:27]1[CH:28]=[C:29]2[C:34](=[CH:35][CH:36]=1)[NH:33][C:32](=[O:37])[CH2:31][CH2:30]2>C(O)CCC.C(O)(C(F)(F)F)=O>[NH2:15][CH2:14][CH:11]1[CH2:10][CH2:9][N:8]([C:6]2[C:5]([CH:23]3[CH2:24][CH2:25]3)=[CH:4][N:3]=[C:2]([NH:26][C:27]3[CH:28]=[C:29]4[C:34](=[CH:35][CH:36]=3)[NH:33][C:32](=[O:37])[CH2:31][CH2:30]4)[N:7]=2)[CH2:13][CH2:12]1

Participants

5

Conditions

Temperature
140 °C

Procedure

A solution of tert-butyl (1-(2-chloro-5-cyclopropylpyrimidin-4-yl)piperidin-4-yl)methylcarbamate (99 mg, 0.27 mmol) and 6-amino-3,4-dihydroquinolin-2(1H)-one (50 mg, 0.30 mmol) in nBuOH (3 mL) was stirred at 116° C. for 20 h. It was then stirred at 140° C. for another 20 h. It was concentrated in vacuo. The residue was purified by HPLC to give a powder, which was then dissolved in TFA (3 mL). After being stirred at room temperature for 20 h, TFA was removed in vacuo. The residue was purified by HPLC to give the titled compound (16 mg). MS 393.5 (M+H); UV 208.9, 264.5 nm

Workup

  1. concentrationIt was concentrated in vacuo
  2. customThe residue was purified by HPLC
  3. customto give a powder, which
  4. stirringAfter being stirred at room temperature for 20 h
  5. customTFA was removed in vacuo
  6. customThe residue was purified by HPLC

Sources & evidence

ORD record
ord-15b6b4d59c9d4ea18242e060e8dfb00f
Source dataset
uspto-grants-2012_09
Patent number
US08258144B2

Reaction notes

Loading…